FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938341655> ?p ?o ?g. }

• W2938341655 endingPage "145" @default.
• W2938341655 startingPage "138" @default.
• W2938341655 abstract "People who inject drugs (PWID) are disproportionately affected by chronic hepatitis C (HCV) in high-income countries. The advent of direct-acting antivirals (DAAs) makes treatment of this underserved population more possible than ever. The dearth of programs adapted to the needs of PWID and stigma associated with drug use and chronic HCV pose significant barriers to the effective uptake of treatment among this population. We employed “life projects” as a conceptual framework to examine the social incentives of PWID being treated for HCV. This study advances the existing literature on the transformative potential of HCV treatment among PWID, explores how these transformations may affect treatment success, and discusses implications for decisions around whether and when to treat PWID. We conducted in-depth interviews with participants of a pilot clinical trial testing the effective delivery of DAA treatment to PWID within two healthcare for the homeless clinic settings – one group receiving opioid agonist therapy (OAT) and another group frequenting a needle and syringe exchange program (NSP). A purposive sample of 27 participants was selected based on place of care. Interviews were transcribed, coded, and analysed for patterns using a priori domains and emergent themes. Participants in both treatment groups described significant life projects that motivated them to complete HCV treatment. These projects included social redemption, strengthening of relationships, pursuit of abstinence from substance use, and harm reduction. These themes were consistent between treatment groups, though more participants in the syringe exchange group relied on harm reduction than on pursuing abstinence to prevent reinfection after achieving virologic cure. Understanding the incentives that propel PWID to complete HCV treatment could help to enhance treatment uptake and adherence through dedicated programs that address current barriers to care." @default.
• W2938341655 created "2019-04-25" @default.
• W2938341655 creator A5023204216 @default.
• W2938341655 creator A5039302741 @default.
• W2938341655 creator A5049522443 @default.
• W2938341655 creator A5049953787 @default.
• W2938341655 creator A5052224040 @default.
• W2938341655 creator A5063082833 @default.
• W2938341655 creator A5083464102 @default.
• W2938341655 creator A5085085849 @default.
• W2938341655 date "2019-10-01" @default.
• W2938341655 modified "2023-10-11" @default.
• W2938341655 title "Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs" @default.
• W2938341655 cites W1553237998 @default.
• W2938341655 cites W1607675442 @default.
• W2938341655 cites W1746911508 @default.
• W2938341655 cites W1799619930 @default.
• W2938341655 cites W1801566764 @default.
• W2938341655 cites W1831293561 @default.
• W2938341655 cites W1963490325 @default.
• W2938341655 cites W1968820944 @default.
• W2938341655 cites W1992468840 @default.
• W2938341655 cites W2033745539 @default.
• W2938341655 cites W2055301074 @default.
• W2938341655 cites W2059950149 @default.
• W2938341655 cites W2061328040 @default.
• W2938341655 cites W2074642337 @default.
• W2938341655 cites W2076872333 @default.
• W2938341655 cites W2089049687 @default.
• W2938341655 cites W2092719720 @default.
• W2938341655 cites W2101910709 @default.
• W2938341655 cites W2115399503 @default.
• W2938341655 cites W2117634494 @default.
• W2938341655 cites W2128731328 @default.
• W2938341655 cites W2139827836 @default.
• W2938341655 cites W2147459444 @default.
• W2938341655 cites W2151183844 @default.
• W2938341655 cites W2154193875 @default.
• W2938341655 cites W2168556746 @default.
• W2938341655 cites W2345197548 @default.
• W2938341655 cites W2485416814 @default.
• W2938341655 cites W2555254640 @default.
• W2938341655 cites W2583596300 @default.
• W2938341655 cites W2609613892 @default.
• W2938341655 cites W2621337851 @default.
• W2938341655 cites W2744191372 @default.
• W2938341655 cites W2750028296 @default.
• W2938341655 cites W2754268575 @default.
• W2938341655 cites W2885311733 @default.
• W2938341655 cites W2906539360 @default.
• W2938341655 doi "https://doi.org/10.1016/j.drugpo.2019.03.015" @default.
• W2938341655 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30995968" @default.
• W2938341655 hasPublicationYear "2019" @default.
• W2938341655 type Work @default.
• W2938341655 sameAs 2938341655 @default.
• W2938341655 citedByCount "27" @default.
• W2938341655 countsByYear W29383416552020 @default.
• W2938341655 countsByYear W29383416552021 @default.
• W2938341655 countsByYear W29383416552022 @default.
• W2938341655 countsByYear W29383416552023 @default.
• W2938341655 crossrefType "journal-article" @default.
• W2938341655 hasAuthorship W2938341655A5023204216 @default.
• W2938341655 hasAuthorship W2938341655A5039302741 @default.
• W2938341655 hasAuthorship W2938341655A5049522443 @default.
• W2938341655 hasAuthorship W2938341655A5049953787 @default.
• W2938341655 hasAuthorship W2938341655A5052224040 @default.
• W2938341655 hasAuthorship W2938341655A5063082833 @default.
• W2938341655 hasAuthorship W2938341655A5083464102 @default.
• W2938341655 hasAuthorship W2938341655A5085085849 @default.
• W2938341655 hasConcept C118552586 @default.
• W2938341655 hasConcept C126322002 @default.
• W2938341655 hasConcept C138816342 @default.
• W2938341655 hasConcept C15744967 @default.
• W2938341655 hasConcept C159110408 @default.
• W2938341655 hasConcept C160735492 @default.
• W2938341655 hasConcept C170493617 @default.
• W2938341655 hasConcept C17744445 @default.
• W2938341655 hasConcept C19417346 @default.
• W2938341655 hasConcept C199539241 @default.
• W2938341655 hasConcept C2776455275 @default.
• W2938341655 hasConcept C2778571141 @default.
• W2938341655 hasConcept C2778767360 @default.
• W2938341655 hasConcept C2778949969 @default.
• W2938341655 hasConcept C2780687700 @default.
• W2938341655 hasConcept C2781063702 @default.
• W2938341655 hasConcept C2908647359 @default.
• W2938341655 hasConcept C2909451232 @default.
• W2938341655 hasConcept C512399662 @default.
• W2938341655 hasConcept C529928208 @default.
• W2938341655 hasConcept C70587473 @default.
• W2938341655 hasConcept C71924100 @default.
• W2938341655 hasConcept C99454951 @default.
• W2938341655 hasConceptScore W2938341655C118552586 @default.
• W2938341655 hasConceptScore W2938341655C126322002 @default.
• W2938341655 hasConceptScore W2938341655C138816342 @default.
• W2938341655 hasConceptScore W2938341655C15744967 @default.
• W2938341655 hasConceptScore W2938341655C159110408 @default.
• W2938341655 hasConceptScore W2938341655C160735492 @default.

• next